San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Aethlon Subsidiary to Collaborate With Thomas Jefferson University in Cancer Research

San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.

By Brittany Meiling April 3, 2015 1:04 p.m.   Share

Cypher Genomics to Partner With Clinic for Special Children

San Diego-based Cypher Genomics Inc., a genome informatics company, and the Clinic for Special Children announced a collaboration in which Cypher's automated genomic interpretation tools will be used for the diagnosis of rare genetic diseases among a specific population.

Gregory Lucier Named CEO at NuVasive Inc.

BIOTECH: He Served As Life Technologies’ CEO for Many Years

NuVasive, Inc., a leading medical device company focused on transforming spine surgery with minimally invasive solutions, announced that Gregory T. Lucier has been appointed chief executive officer, effective immediately.

Tease photo

Confidentiality Vital For Recovery Center

HEALTH: First Responders Bring Big Privacy Issues

When Scott Silverman looked for a drug treatment facility after years of addiction, the demographics of his fellow patients was not a pressing concern.

Tease photo

Sector Shifts as Biofuel Is Running Out of Gas

BIOTECH: Food Products, Supplements Are Options

Let’s be honest, biofuel was a bit of a bust.

Viking Therapeutics Says IPO Underwriters Purchasing Extra Shares

Viking Therapeutics Inc., a clinical-stage biopharmaceutical company, announced Friday that the underwriters for its recent initial public offering have exercised their option to purchase from Viking an additional 450,000 shares at the initial offering price to the public of $8 per share.

Jack Lief to Step Down from Mast Therapeutics' Board

Mast Therapeutics Inc., a biopharmaceutical company in San Diego, announced Thursday that Jack Lief will be resigning from the company's board of directors.

Tease photo

Freedom Meditech Inc. Appoints John Gerace CEO

Medical-device maker Freedom Meditech Inc. announced Thursday that it has appointed John Gerace, most recently of Life Technologies, as its chief executive officer and a member of the company's board of directors.

Zogenix Hopes to Use Obesity Drug to Fight Childhood Seizures

San Diego drugmaker Zogenix said Wednesday that a drug once used to fight obesity before it was taken off the market may help treat a rare disease that causes severe seizures in young children.

Corporate Wellness Symposium Being Held May 27

Deepak Chopra, the well-known alternative medicine practitioner, is launching the 2015 Corporate Wellness Symposium, a day-long seminar for HR executives and wellness practitioners in Carlsbad on May 27 at the LaCosta Resort and Spa.

Tease photo

Gregory Lucier Named Permanent CEO at NuVasive

NuVasive, Inc., a leading medical device company, announced that Gregory T. Lucier has been appointed chief executive officer, effective immediately. Lucier has been serving as interim CEO since April and will continue as chairman of the NuVasive board of directors.

Cos. Don’t Have to Pull the Plug After Clinical Trial Failures

MEDICINE: They Can Make Aggressive Cuts, Pursue Other Avenues

Those in the science business must learn to roll with the punches when clinical trials flop, especially when the companies are public, and the failures are broadcast on a global stage, industry veterans said.

Eli Lilly to Collaborate With Institute

Sanford-Burnham Medical Research Institute will collaborate with Eli Lilly and Co. to develop immunological therapies, the companies announced.

Tease photo

Foundry Medical Innovations Merging With Zeis to Become Toolbox Medical Innovations

Foundry Medical Innovations, a medical and diagnostic device development company in Carlsbad, has merged with Zeis Consulting Group, an IVD clinical research firm.

Cidara Therapeutics Reports Q1 Results

Cidara Therapeutics Inc. reported May 21 a net loss of $6.7 million for the first quarter of 2015, up from a net loss of $707,000 in the same quarter of last year.

Lpath to Cut Jobs After Eye Drug Fails Study

San Diego drug developer Lpath Inc. said it would cut jobs and costs after its experimental eye drug failed a mid-stage study in patients with wet age-related macular degeneration, a leading cause of blindness in the elderly.